Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,864 INR | +0.48% | +4.81% | +14.75% |
Sales 2024 * | 35.01B 420M | Sales 2025 * | 40.58B 487M | Capitalization | 289B 3.47B |
---|---|---|---|---|---|
Net income 2024 * | 5.64B 67.65M | Net income 2025 * | 7.06B 84.7M | EV / Sales 2024 * | 8.3 x |
Net Debt 2024 * | 1.32B 15.81M | Net cash position 2025 * | 4.41B 52.94M | EV / Sales 2025 * | 7.02 x |
P/E ratio 2024 * |
48.4
x | P/E ratio 2025 * |
38.7
x | Employees | 5,095 |
Yield 2024 * |
0.65% | Yield 2025 * |
0.77% | Free-Float | 45.82% |
Latest transcript on J. B. Chemicals & Pharmaceuticals Limited
1 day | +0.48% | ||
1 week | +4.81% | ||
Current month | +13.01% | ||
1 month | +15.56% | ||
3 months | +10.34% | ||
6 months | +42.09% | ||
Current year | +14.75% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 20-10-04 | |
Bharat Dhanani
COO | Chief Operating Officer | - | - |
Sujay Rajhans
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20-08-30 | |
Akshay Tanna
BRD | Director/Board Member | 40 | Nov. 06 |
Gaurav Trehan
BRD | Director/Board Member | 48 | 21-02-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.14% | - | |
0.00% | 117 M€ | +1.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1,864 | +0.48% | 973 |
24-04-25 | 1,855 | +1.69% | 7,046 |
24-04-24 | 1,824 | +2.30% | 4,047 |
24-04-23 | 1,783 | -0.16% | 4,204 |
24-04-22 | 1,786 | +0.44% | 2,693 |
Delayed Quote Bombay S.E., April 26, 2024 at 06:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.75% | 3.47B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- JBCHEPHARM Stock